Enter your email address to receive updates
Search By Trade Name
Trade name | Generic name | Classification
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z 
Generic Name
Oxprenolol
Trade Name
Trasicor
Manufacturer
Novartis pharma
Risk Category
C*
  • Studies on animals show adverse effect and toxicity on fetus.
  • No adequate and well controlled studies done on pregnant women.
  • Drugs should be given only if the potential benefit outweighs the potential risk to the fetus.
The risk category is D only if used in second and third trimester.
FDA Pregnancy Risk Categories

Place (not click) your mouse cursor over the bold words in the text below to receive description

Indication
Indication
  • sympatholytic (nonselective β adrenergic blocker).
  • Antihypertensive.
  • Fetal Risk
    Fetal Risk
  • croses human placenta.
  • No well – controlled human data, no association with congenital malformations has been reported in 1st trimester exposure.
  • Use of β blockers in the last two trimester is associated with intrauterine growth retardation and persistent neonatal β blockade.
  • Data for this agent are limited.
  • Breast Feeding
    Breast Feeding
  • Excreted into milk.
  • Safe in breast feeding but infants should be observed for possible β blockade.
  • Other Trade Names
     
    The information on this Web site is not intended as a substitute for the advice and care of your doctor or other health-care provider. Always consult your doctor if you have any questions about exposures during pregnancy and lactation, and before you take any medications. Please read the Terms and Conditions before using this website.
      Tell A Friend

        You
    Name
    Email
        Your Friend
    Name
    Email
        Comments
     4   +   10    =  
      Calculate Birth Date
    Enter the first day of the last menstruation
    Month Day Year
    Result
    Month Day Year